Loading page content…
Loading page content…
Loading contract search results…
275 matching tenders · Click a result to see its full lifecycle · Updated daily · Contracts Finder + Find a Tender Service
Write bids with AI
Draft tender responses with BidWriter. New monthly software subscriptions: one normal monthly payment upfront covers 3 calendar months, then monthly billing starts in month 4. Annual plans excluded; cancel renewal anytime.
Get 3 months for the price of 1 →Ealing Council intends to appoint a suitably qualified and experienced Supplier(s) to deliver its two-Lot Highways Works Term Contract. • Lot 1 – Highways Maintenance Works • Lot 2 – Highway & Civil Improvements
Project title: NHS National Framework for Lenvatinib Offer reference number: CM/TNS/26/5751 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months. CM/TNS/26/5751 Lenvatinib Lot 1 CESW: 01/06/2027 to 31/01/2029 (20 months) Lot 2 NWLN: 01/06/2027 to 30/09/2028 (16 months) Lot 3 LSNE: 01/06/2027 to 31/05/2028 (12 months) Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
Marketing services for Development schemes with estimated value £7.6m over 3+1 years
Supply Chain Coordination Limited (“NHS Supply Chain”) intends to procure a National Framework Agreement for the supply of Medical Examination Gloves including but not limited to: 6N Examination Gloves: 6N Nitrile Exam Gloves Examination Gloves Specialised Following further review of the category strategy, market landscape, and customer requirements, it has been concluded that Medical Examination Gloves and Surgical Gloves will be procured through separate frameworks. Whilst the original PME notice (2025/S 000-052117) indicated an intention to combine the two categories into a single framework, subsequent analysis identified that they operate as distinct markets with differing customer needs, supply bases, technical specifications, and procurement considerations. In addition, the categories are subject to different commercial models, pricing mechanisms, market dynamics, and contract management requirements. Maintaining separate frameworks will enable a more tailored procurement approach for each category, support effective category management, and better align with customer and market needs. This revised approach is expected to enhance supplier engagement, promote competition, and provide greater flexibility to respond to future market developments and evolving customer demand. We are looking at ways to review the procurement strategy and simplify commercials in terms of agreements and pricing points, rationalise ranges for stocked product. This framework will continue to incorporate sustainability requirements for third party social audits across Medical Examination Gloves. NHS Supply Chain is assessing the most appropriate procurement approach, and the tendering procedures that may be used for future contract awards. The Framework Agreement will be entered into between the Authority and individual Supplier(s). The Authority may purchase goods under the Framework Agreement, which will be made available for purchase by: • any NHS Trust; • any other NHS entity; • any government department, agency or other statutory body (for the avoidance of doubt including local authorities); and/or • any private sector entity active in the UK healthcare sector. The award of a place on the Framework Agreement does not guarantee any commitment by the Authority or its customers to place any orders under the Framework Agreement. To participate in NHS Supply Chain procurements, Tenderers must be registered on the Central Digital Platform (CDP) and have shared their information with NHS Supply Chain via the CDP. The CDP is available at: https://www.gov.uk/findtender Please ensure your details match your account details in Jaggaer, Companies House and CDP. It is the Suppliers responsibility to ensure the account set up in Jaggaer is in the correct company name. For example, if the name has been set up incorrectly or the business has had changes to its organisation we recommend the following: Incorrect Name (such as typo) - Contact Jaggaer via the help options (seen on page after logging in) and explain that the details are incorrect and provide correct details. Company organisation Changes - 2 options: Note: Audit trails need to be maintained in Jaggaer which makes it difficult to allow changes to business that have had significant changes such as merges of businesses or been purchased by other organisations. Option 1: Create a new account with new name (preferred). Option 2: Current account - Contact Jaggaer via the help options (seen on page after logging in) and provide details of the changes (such as a company name change document from companies house). Tenderers must also be registered on Jaggaer, as all tender activity will be conducted through this system. The Tenderer is responsible for ensuring that its Jaggaer account is set up in the correct company name and that all information is kept up to date. Jaggaer can be accessed via https://nhssupplychain.app.jaggaer.com The Authority estimates that, in the first 12 months of the Framework, the total value of purchases will be approximately £125,000,000 excluding VAT. Over the full 48-month term, the estimated total value is approximately £500,000,000 excluding VAT. These values are indicative only and do not constitute any guarantee of business with successful Tenderers. The following requirements are anticipated to apply but are not exhaustive and may be updated in accordance with applicable legislation and/or relevant guidance (please refer to the requirements set out in the ITT): • ISO Certification Tenderers must hold ISO 9001: 2015, ISO 13485:2016 or Medical Device Single Audit Program (MDSAP) certification, accredited by the United Kingdom Accreditation Service (UKAS) or internationally recognised equivalent. The certification must cover all relevant elements of the Tenderer’s and the product(s)’ supply chain, including (but not be limited to) sales, manufacturing, storage and distribution. Acceptable UKAS alternatives are listed at: https://global-aci.org/en/full-members • CE Certification and Declaration of Conformity Where applicable, valid CE Certification and Declarations of Conformity must be submitted at the tender submission stage. • Modern Slavery Statement Tenderers with an annual turnover of £36 million or more must comply with the Modern Slavery Act 2015, publish an annually updated Modern Slavery Statement on their website, and provide a link to that statement. • Modern Slavery Assessment Tool (MSAT) Tenderers must have achieved an MSAT score of 41% or above within 12 months prior to the tender close date. The assessment results must be shared with NHS Supply Chain via the ‘share’ function on the Supplier Registration Service (SRS) Portal, available at: https://supplierregistration.cabinetoffice.gov.uk • Third-party Audit Tenderers must provide evidence of third-party social audits for manufacturing facilities supplying products under the Framework. Audit requirements are expected to include assessment against forced labour risks, including the 11 International Labour Organisation (ILO) Forced Labour Indicators. NHS Supply Chain continues to review its responsible sourcing approach and, as such, third-party audit requirements may be developed further during the procurement process. Further details will be provided within the ITT documentation. • Evergreen Sustainable Supplier Assessment Tenderers must have completed the Evergreen Sustainable Supplier Assessment and achieved Level 1 or above within 12 months prior to the Tender Close Date. Guidance and access are available at: https://www.england.nhs.uk/nhs-commercial/central-commercialfunction-ccf/evergreen • Carbon Reduction Plan (CRP) Tenderers must provide a valid Carbon Reduction Plan (CRP) link on their website that meets the requirements of PPN 006. • Cyber Security Tenderers that handle patient or personal data, or provide IT systems, services, or devices, must either: • hold a valid Cyber Essentials Plus Certificate; or • where the Tenderer does not have a Cyber Essentials Plus Certificate, submit a completed Information Security Third Party Questionnaire (ISTPQ). • Distribution Agreements If tendering as a Distributor, the Tenderer must provide written evidence from the relevant Original Equipment Manufacturer(s) (OEM) confirming that they have rights to distribute goods for the Term as defined in the Framework Agreement Award Pack. If the Term is extended, Distributors must provide further written evidence from the OEM confirming that they have rights to distribute goods for the remaining Maximum Term as defined in the Framework Agreement Award Pack.
NHS South West London Integrated Care Board (the Authority) is seeking to commission a Mental Health Support Team (MHST) service comprising 25 operational and developing MHSTs across the six boroughs. The service will provide prevention and early intervention mental health support through a standardised and equitable MHST offer, in accordance with the specified requirements, to improve access to care, reduce health inequalities, and deliver improved outcomes for children and young people across South West London. Procured through a competitive process under the Health Care Services (Provider Selection Regime) Regulations 2023, the Authority intends to appoint a Lead Provider with overall accountability for the governance, management, and delivery of the service. The Lead Provider will oversee all operational and developing MHSTs across South West London and will be responsible for the mobilisation, delivery and service integration of future MHST teams required as part of the planned expansion to achieve 100% MHST coverage across South West London by December 2029. The decisions applicable to this Procurement will be made by the Authority. The Procurement is being managed by NHS London Commercial Hub (NHS LCH) hosted by NHS North East London, on behalf of the Authority, in connection with an Invitation to Tender (ITT) exercise that is being conducted, based on the competitive process under the Health Care Services (Provider Selection Regime) regulations 2023 ("the Regulations"(as amended). None of the references to "ITT", "Bid", or the use of the term "tender process", or any other indication, shall be taken to mean that the Authority intends to hold itself bound to any of the Regulations, save those applicable to PSR provisions regarding the Competitive Process. Further information regarding the Authority is available from: https://www.southwestlondon.icb.nhs.uk/ The lifetime Value of the contract is £89,916,960 excluding VAT. The contract term is for three (3) years with an option for extension of further three (1 + 1 + 1) years at the sole discretion of the Authority. The contract will start on 01/04/2027 and end 31/03/2030, if the 1 + 1 + 1 optional extensions are utilised the maximum contract end date will be 31/03/2033. The maximum duration of the contract is 6 years (72 months). Further details of the procurement, including service requirements are included in the procurement documents.
Decarbonisation Refurbishment works at Sheen Lane Centre & Teddington Pool
The contract is expected to initially be delivered for NHS-funded care in England and Wales, and publicly funded care in Jersey for a period of three years, at a maximum total budget of up to £933,979.20 GBP including VAT and £778,316.00 GBP excluding VAT. Bids exceeding this limit will be rejected. There is potential to extend the contract for up to two additional years as well as the option to include other Devolved Nations and/or Crown Dependencies, aspirational measures and discretionary inflationary uplifts (all of which will be defined in the service specification). The maximum budget ‘core’ value of £933,979.20 GBP including VAT and £778,316.00 GBP excluding VAT, excludes the potential two-year extension and aspirational intent as included in section 14.4 of Annex A - Service Specification The contract may be extended for up to 24 months at a pro rata value of the core three- year funding, estimated at up to £518,877 excluding VAT. This proposed extension value may also include pro rata funding of any additional aspirational measures invoked in the first three years of the contract. For example: If an aspirational annual requirement costing £500,000 per year is invoked in year three, then the extension funding (if the aspirational measure is continued) will be the above figures plus the additional £500,000 per year. Further to this funding, the specification contains a list of aspirational measures which will be expected to be modified into the contract should the need and funding become available. The aspirational intent value, including the potential two- year extension and core 3 year value means an overall ceiling value for this contract of up to £6,417,788 excluding VAT and £7,701,346 including VAT. This aspirational intent has the potential to be invoked fully, partially, or not at all, and the Authority cannot guarantee that the successful supplier will be required to do any of the aspirational measures listed in section 14.4 of Annex A - Service Specification The role of a national clinical audit is to stimulate healthcare quality improvement through the provision of high-quality information on the organisation, delivery and outcomes of healthcare, together with tools and support to enable healthcare providers and other audiences to make best use of this information. Outcomes are benchmarked against available national guidance and standards e.g. quality standards from the National Institute for Health and Care Excellence (NICE), and those from other established professional and patient sources. Successful national audits are those where the individuals who are engaging with and using the audit results are also in a position to improve the system, and where there is a shared understanding of what good care looks like. National clinical audits are expected to: a.Develop a robust, high-quality audit designed around key quality metrics likely to best support local and national healthcare quality improvement. b.Detect, describe and help reduce unwarranted clinical variation by systematically benchmarking performance, identifying outliers, and supporting services to understand variation in outcomes, processes and experience. c.Achieve, articulate and maintain close alignment with relevant NICE national guidance and quality standards throughout the audit, as appropriate. d.Enable healthcare quality improvement through the provision of timely, high-quality data that compares providers of healthcare, and comprises an integrated mixture of named Trust or Health board, Integrated Care System (ICS), commissioner, multidisciplinary team (MDT), possibly consultant or clinical team level and other levels of reporting. e.Engage patients, carers and the public in a meaningful way, achieving a strong patient voice which informs and contributes to the design, functioning, outputs and direction of the audit. f.Consider the value and feasibility of linking data at an individual patient level to other relevant national datasets either from the outset or in the future and plan for these linkages from the inception of the contract. g.Ensure robust methodological and statistical input at all stages of the audit. h.Identify from the outset the full range of audiences for the reports and other audit outputs and plan and tailor them accordingly. i.Provide audit results in a timely, accessible and meaningful manner to support healthcare quality improvement, minimising the reporting delay and providing continual access to each unit for their own data. j.Utilise strong and effective project and programme management to deliver audit outputs on time and within budget. k.Develop and maintain strong engagement with local clinicians, networks, commissioners, patients and their families and carers and charity and community support groups to drive improvements in services. l.Deliver high-quality audit outputs, benchmarking and quality improvement as a priority. At the time of writing the specification, requirements include (but please also refer to the potential future aspirational intent section): 1. Audit Purpose The overall ambition of the audit is to continue to capture and report data on the performance of individual healthcare providers against the National Institute for Health and Care Excellence (NICE) Quality Standard QS33: Rheumatoid Arthritis in Adults, Quality standard QS214: Rare diseases, and other relevant national standards and guidance, (see Appendix 1). 2. Paediatric Inflammatory Arthritis Pathway The supplier should work with the wider Dataset and Methodology Stakeholder Group to develop, maintain and report against a minimum viable paediatric inflammatory arthritis pathway. The initial focus should be on establishing a clinically meaningful dataset and reporting framework sufficient to describe the patient pathway and support audit activity. Initial measures should focus on a limited number of priority areas agreed with funders and stakeholders, for example referral, diagnosis and treatment timelines. The updated GIRFT Paediatric Inflammatory Arthritis Pathway guidance, anticipated for publication in January 2027, should be considered a key reference for the future development of the dataset, measures and reporting framework. The supplier should work with the wider Dataset and Methodology Stakeholder Group to review and align the dataset, metrics and reporting outputs with the recommendations and standards set out within the GIRFT guidance, ensuring ongoing relevance and consistency with national best practice. Any expansion beyond the core pathway, including additional metrics, PROMs/PREMs, transition measures and broader pathway development, should be considered future aspirational intent subject to feasibility, resources and further funding. 3. Data Collection and Audit Design The supplier should continue to deliver a continuous prospective clinical audit and work with the Dataset and Methodology Group to ensure the audit dataset remains clinically relevant and proportionate. The supplier is expected to collaborate with specialist disease-specific clinical groups to support interpretation of findings and improve case ascertainment and recruitment rates. 4. Organisational Survey and Quality Improvement The supplier should review and maintain the organisational survey to ensure it remains proportionate and aligned with audit objectives. Priority should be given to maximising analysis and utilisation of existing data rather than increasing data collection burden in collaboration with the wider Dataset and Methodology Stakeholder Group. The organisational survey should support the audit's quality improvement objectives by enabling a deeper understanding of service delivery, workforce capacity, variation in practice and barriers to high-quality care. 5. Benchmarking and Improvement The audit is expected to support continuous improvement across all services. While identifying high-performing and outlier services remains important, the audit should also support improvement among services performing at or around the national average, where the greatest overall gains may be achieved. Benchmarking should encourage year-on-year improvement within individual services and provide meaningful insights that motivate all providers to improve, regardless of their current position relative to national performance. 6. Targeted improvement support The supplier should provide targeted quality improvement support following each annual audit cycle. Activities should build on existing professional networks, collaboratives and stakeholder infrastructure wherever possible rather than creating wholly new arrangements. Improvement support should be designed to benefit healthcare providers across the performance spectrum, including those performing at a middle level where the greatest overall gains may be achieved, while also supporting services experiencing significant challenges or demonstrating exceptional practice. Learning generated through quality improvement activities should be shared with all participating healthcare providers to maximise the impact of the audit programme. The anticipated outputs are: 1.Near real-time dynamic and interactive metric results. 2.Publication of an annual state of the nation report with the inclusion of an organisational survey. 3.Incorporation of validated Patient Reported Outcome Measures. 4.Quality improvement resources. 5.The identification and notification of outliers. For further information on the current audit, currently delivered by the British Society for Rheumatology (BSR) please head to: https://www.rheumatology.org.uk/improving-care/audits/neiaa
The purpose of this Framework is to provide specialist safety and assurance services across the Northwest and Central Region. These services support compliance with Commission Implementing Regulation (EU) No 402/2013 of 30 April 2013 on the Common Safety Method for Risk Evaluation and Assessment (CSM REA), as amended and applied in Great Britain and as invoked by the Railways and Other Guided Transport Systems (Safety) Regulations 2006 (as amended), the Railways (Interoperability) Regulations 2011 (as amended), and all associated Network Rail and rail industry standards and guidance.
Non-exclusive framework agreement for the supply of Medical Pulp Associated Products via the Stock, eDirect and Direct route to market. This includes but is not limited to; a range of products that are used to assist with the toileting of patients, collection of samples and aid the administration of procedures. The ranges of products available under the framework agreement include; Disposable Medical Pulp, Medical Pulp support products, Macerators, Bedpan Washers and Absorbent products for use with Medical Pulp. This framework agreement is for a total of 48 months. Precise quantities are unknown, however, it is anticipated that expenditure will be in the region of £120,000,000 ex VAT / £144,000,000 inc VAT throughout the duration of this framework agreement. This is approximate only and the values may vary depending on the requirements of those bodies purchasing under the framework agreement.
Lift Maintenance for Wandsworth Council Housing and Richmond and Wandsworth Operational Buildings (3 lots)
The procurement of Corporate Property, Liability and Terrorism insurance for the Insurance London Consortium (ILC): London Borough of Croydon London Borough of Camden London Borough of Haringey London Borough of Harrow London Borough of Islington London Borough of Lambeth London Borough of Tower Hamlets The procurement is divided into the following 3 lots: Lot 1 - Property Lot 2 - Terrorism Lot 3 - Casualty The Authorities intend to award a contract for a period of five (5) years. Contracting Authority: London Borough of Croydon, Bernard Weatherill House, 8 Mint Walk, Croydon CR0 1EA on behalf of; London Borough of Camden London Borough of Haringey London Borough of Harrow London Borough of Islington London Borough of Lambeth London Borough of Tower Hamlets
• Establish a compliant multi lot framework that delivers value for money, quality, and continuity of supply. The framework will be divided into the following lots, Lot 1 New Build(Supply Only and Lot 2 Major Works/Refurbishments (Supply Only). L&Q intends to appoint a minimum of two suppliers but reserves the right to appoint more or fewer depending on the outcome of the procurement. • L&Q intends to procure the Framework using a three-stage Competitive Flexible Procedure comprising Stage 1 - Selection Questionnaire (PSQ), Stage 2 - Invitation to Tender (ITT), and Stage 3 - Negotiation and Best and Final Offer (BAFO), followed by contract award. A minimum of the top three ranked Tenderers from the ITT stage will ordinarily be invited to participate in the BAFO stage; however, L&Q reserves the right, at its sole discretion, to invite any number of Tenderers to this stage. • As part of the BAFO stage, L&Q may require Tenderers to participate in clarification meetings, interviews, presentations, demonstrations, and/or site visits to further evaluate proposals and inform the final assessment. The meetings may take place face to face or virtually online. Details of any such activities, including the evaluation approach and scoring methodology where applicable, will be communicated to Tenderers in advance. • L&Q also reserves the right not to undertake Stage 3 - Negotiation and Best and Final Offer (BAFO) and may proceed directly to contract award following Stage 2 - Invitation to Tender (ITT) where it considers this to be appropriate. • Ensure commercial certainty and added value, requiring fixed pricing for a minimum of 12 months from Framework commencement, delivery of social value equivalent to 1% of the end of year contract value, and the inclusion of plot based rebates where applicable.
MyEnds 3.0 is an evolved version of the flagship VRU MyEnds programme which will run from April 2027 until March 2029. This new iteration will allow us to implement key learning from the MyEnds programmes and strengthen the key components of the overall programme design, optimising innovation with more targeted strategic alignment. The MyEnds programme utilises a hyper-local approach to address needs in neighbourhoods across the capital that are most affected by high and sustained levels of violence. The core model endorsed by the VRU for this programme is based on the empowerment of communities, recognising the critical role and collective impact community stakeholders have in local violence reduction initiatives. This is achieved through the delivery of key activity strands, including strengthening local partnerships, young people and community participation, capacity building of the grassroots sector, and the delivery of locally informed interventions. The VRU is seeking Provider(s) to deliver the programme across eligible boroughs. Eligible Boroughs: 1. Lambeth 2. Croydon 3. Southwark 4. Tower Hamlets 5. Newham 6. Enfield 7. Haringey 8. Hackney 9. Lewisham 10. Islington 11. Camden 12. Brent 13. Hillingdon 14. Greenwich 15. Wandsworth 16. Barking and Dagenham For more information about this opportunity, please visit the eSourcing portal at: https://www.delta-esourcing.com/tenders/UK-UK-London:-Provision-of-services-to-the-community./BFD3YHK9GF To respond to this opportunity, please click here: https://www.delta-esourcing.com/respond/BFD3YHK9GF
MyEnds 3.0 is an evolved version of the flagship VRU MyEnds programme which will run from April 2027 until March 2029. This new iteration will allow us to implement key learning from the MyEnds programmes and strengthen the key components of the overall programme design, optimising innovation with more targeted strategic alignment. Background to Current Service : The MyEnds programme utilises a hyper-local approach to address needs in neighbourhoods across the capital that are most affected by high and sustained levels of violence. The core model endorsed by the VRU for this programme is based on the empowerment of communities, recognising the critical role and collective impact community stakeholders have in local violence reduction initiatives. This is achieved through the delivery of key activity strands, including strengthening local partnerships, young people and community participation, capacity building of the grassroots sector, and the delivery of locally informed interventions. Evidence shows that a community-led approach, by those who know their area and its challenges best, is the most effective way to prevent violence. MyEnds provides communities with the tools and resources to deliver their own prevention measures. This includes support networks for parents and carers, after-school activities, youth work in neighbourhood youth clubs, mentoring and targeted support interventions. Service Requirements The VRU Area Prioritisation Tool, previously used to identify areas for the 2019 MyEnds pilot and MyEnds 2.0, has been refreshed with updated data and metrics to identify eligible locations for MyEnds 3.0. The tool identifies ward-level areas that have consistently ranked within the top 15% of London wards across a range of violence and public health indicators between 2021 and 2026. Based on this analysis, the 16 boroughs containing the highest-scoring wards have been shortlisted as eligible for the programme. The VRU is seeking community-based organisations or consortium bids led by a lead provider to deliver the programme across these boroughs. Bidders will be invited to provide additional evidence of local need within their proposed delivery locations as part of the application process. Eligible Boroughs: 1. Lambeth 2. Croydon 3. Southwark 4. Tower Hamlets 5. Newham 6. Enfield 7. Haringey 8. Hackney 9. Lewisham 10. Islington 11. Camden 12. Brent 13. Hillingdon 14. Greenwich 15. Wandsworth 16. Barking and Dagenham For more information about this opportunity, please visit the eSourcing portal at: https://www.delta-esourcing.com/tenders/UK-UK-London:-Provision-of-services-to-the-community./U8A8R2K7R9 To respond to this opportunity, please click here: https://www.delta-esourcing.com/respond/U8A8R2K7R9
UK Sport is seeking a suitably qualified supplier to deliver its Athlete Medical Scheme, providing timely, high-quality healthcare to eligible funded athletes. Tenderers may propose a fully insured model, a trust-based model, or both. The contract will cover the administration and management of the scheme, access to an appropriate healthcare provider network, claims handling, management information and performance reporting. The contract will commence on 1 April 2027 for an initial three-year term, with the option to extend for a further year. Please see more detail in the ITT.
Opportunity Non-exclusive framework agreement for the supply of Laser and Thermal printable wristbands, Thermal Printers- (Direct Thermal Printer, desktop or mobile model which are handheld and/or standalone) and associated accessories e.g. – battery packs, docking stations, printer ribbons, handheld electronic devices such as barcode scanners. Digital/contactless identification: Radio Frequency Identification (RFID) hardware and software, Near-field communication (NFC) products for access i.e. smart badges, ID badges in general etc, Biometric identification and card printers. This framework agreement is for a total of 48 months. Precise quantities are unknown. It is anticipated that the expenditure will be in the region of GBP £40,000,000 - £50,000,000 Ex VAT / £48,000,000 - £60,000,000 Inc VAT throughout the duration of this framework agreement. However, this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the framework agreement. Requirements The following certification will be a requirement of the upcoming tender exercise and Applicants may be required to include evidence of this within their tender submission: - Employer's Liability Insurance cover of £5m per claim in the name of the Applicant - Public Liability Insurance cover of £5m per claim in the name of the Applicant - Product Liability Insurance cover in the name of the Applicant of £5m per claim or £5m per claim and in the annual aggregate - ISO9001:2015 accredited by the United Kingdom Accreditation Service (or international equivalent) to cover all segments of the Applicant's and the product's supply chain. This should include, but not be limited to, manufacturing, storage and distribution. - Declaration of Conformity and UKCA/CE Certification to demonstrate compliance to Medical Devices Regulations 2002 (if applicable). PPN 009 'Tackling Modern Slavery in Government Supply Chains' In February 2025 PPN 009 "Tackling Modern Slavery in Government Supply Chains" was published. This PPN specifically calls out the NHS as being in scope. The PPN requires the risk of Modern Slavery to be identified for each Procurement activity, and appropriate due diligence conducted to manage these risks. Risk Profiling and Methodology Each NHS Supply Chain procurement, including the forthcoming procurement for Patient Identification has been assessed, using a standard methodology. The methodology has been developed using a database of risk, mapped to E-class codes. This has been mapped to the procurement activity to assess the level of risk associated with that activity, prior to knowing which specific suppliers and value chains are going to be used. Based on that risk the following tools will be applied to the procurement to understand the specific risk in the proposed supply chains. Low Risk - Modern Slavery Assessment Tool Medium Risk - Modern Slavery Assessment Tool + Evidence Review High Risk - Modern Slavery Assessment Tool + Evidence Review + 3rd Party Audit This risk profiling has been conducted on Patient Identification products in the pre-market phase and has determined a medium risk. PPN 009 Tender Submission Requirements Confirmation (yes/no) that The Modern Slavery Assessment Tool has been completed - will form part of the Selection Questionnaire of the tender. Results will be evaluated to establish Supplier risk. Evidence Review on Modern Slavery - will be evaluated at tender submission. Results will be evaluated to establish Supplier risk. Actions for Suppliers/Potential Suppliers to take now in the Pre-Market Stage Ensure you have completed the Modern Slavery Assessment Tool (MSAT), you have a plan in place to act on the recommendations it makes, and you maintain the assessment annually. Risks are based on the 6 factors set out in PPN 009. The NHS has adopted PPN002 (taking account of Social Value), and therefore this future Framework Agreement will require suppliers to state what is their Social Value proposition which in turn will be made available to customers who utilise the Framework Agreement to aid their decision making when using the framework. In addition, the NHS has adopted the Government's 'Taking Account of Carbon Reduction Plans' PPN006 requiring all suppliers with new contracts for goods, services and/or works irrespective of value to publish a carbon reduction plan for their direct emissions. Suppliers bidding on NHS Supply Chain tenders will also be required to submit an Evergreen Assessment. For further information on NHS Supply Chain's application of PPN002 and PPN006 in addition to Evergreen Assessment and Horizon scanning requirements, a Sustainability & Social Value document will be issued to all suppliers who express interest in this Pre Market Engagement Notice along with the RFI. In any case, the Sustainability & Social Value document will also be made available with the full tender documents which will be the subject of separate market notice. Suppliers are required to be registered on the Central Digital Platform by using the following link; Suppliers: How to register your organisation and first administrator on Find a Tender in three easy steps (HTML) - GOV.UK The Framework Agreement between NHS Supply Chain and successful suppliers will reserve the right to purchase the same or similar supplies and/or services from suppliers not appointed to the Framework Agreement at its sole discretion. As part of its pre-tender strategy, NHS Supply Chain would also like to engage with suppliers of these products via a Request for Information (RFI). If you would like to complete the Request for Information document in respect of the products which are the subject of this procurement then please follow the below instructions; REGISTRATION 1. Use URL https://nhssupplychain.app.jaggaer.com// to access the NHS Supply Chain Procurement portal. 2. If not yet registered: - Click on the 'Not Registered Yet' link to access the registration page. - Complete the registration pages as guided by the mini guide found on the landing page. PORTAL ACCESS If registration has been completed: - Login with URL https://nhssupplychain.app.jaggaer.com// - Click on "ITT's Open to All Suppliers" EXPRESSION OF INTEREST - Find " ITT_2422" and click on the blue text. Select Express interest. If you have any queries regarding the NHS Jaggaer E-procurement Portal or completing your expression of interest on this system, please contact our Support Helpdesk managed by Jaggaer on telephone: 0800 0698630 or by E-mail: [email protected]
NHS Supply Chain is preparing a national framework agreement that will support the procurement of dental consumables, clinical solutions, equipment, digital technologies, diagnostics, and practice infrastructure, structured across the following indicative lots: The following lot structure is indicative and subject to final confirmation: Lot 1: Dental Consumables & Appliances Lot 2: Specialist Clinical & Bespoke Solutions Lot 3: Operatory Equipment Lot 4: Dental Laboratory & Digital Solutions Lot 5: Dental Imaging & Diagnostics Lot 6: Dental Environment, Decontamination & Practice Building Lot 7: Mobile Dental Clinics & Equipment Note: For future tenders the following requirements will apply: • ISO Certification: Tenderers must have ISO 9001: 2015 or BS EN ISO 13485:2016 certification or Medical Device Single Audit Program (MDSAP) certification accredited by the United Kingdom Accreditation Service (UKAS) (or international equivalent) to cover all segments of the Tenderer’s and the product’s supply chain. This should include, but not be limited to, sales, manufacturing, storage and distribution ('ISO Certification'). Link for acceptable alternatives https://iaf.nu/en/accreditation-bodies/ (‘Notified Bodies’). • CE Certification and Declaration of Conformity certificates are required where applicable to be presented at submission stage of the tender. • Modern Slavery for Tenderers that have an annual turnover of at least £36 million must have a link to their modern slavery statement on their website • Modern Slavery Assessment Tool (MSAT) Tenderers must have a score of 41% or above within 12 months of the Tender Publication Date via https://supplierregistration.cabinetoffice.gov.uk/ • Evergreen Sustainable Supplier Assessment – Tenderers will need to have completed the assessment and achieved Level 1 within the 12 months prior to the Tender Close Date. Link for instructions and access for this assessment: https://www.england.nhs.uk/nhs-commercial/central-commercial-function-ccf/evergreen/ • Carbon Reduction Plan (CRP): Tenderers must have a valid CRP link on their website that meets the requirements of PPN 006 as outlined in the PPN, OR Where Supplier has no website, the CRP is provided in PDF format that meets the requirements of PPN 006 as outlined in the PPN, OR Excused in exceptional circumstances. • Cyber Security: If you handle patient or personal data, or provide any IT systems, services, or devices you will need to have a Cyber Security Essentials Plus Certificate.
The Court Funds Office (CFO) provides a banking and investment service for the civil courts in England and Wales, including the Court of Protection. The CFO exists to discharge the legal responsibilities of the Accountant General (AG). It is the AG’s responsibility to safeguard funds in court. The Administration of Justice Act 1982 (Primary) and Court Funds Rules 2011 (Secondary Legislation) provide for CFO’s statutory requirements. The Office of the Accountant General (OAG), part of the MoJ, provides oversight over the services provided by the CFO. The CFO service, under the instructions of the Court, allows for deposits to be lodged, paid out and to interact with the Lord Chancellor’s equity Investment product (Tracker Fund) provided by Legal & General for court clients {mainly Children and Court of Protection Clients (CoP)}. CFO also provides operational and back-office services for all said activities. Given the specific rules and regulations, the current service provided includes bespoke and manual requirements not ordinarily provided by a banking service provider. This procurement aims to deliver a solution that enables the complete digital transformation of the CFO service, providing clients with secure, web-based access to account information and processing, while removing legacy barriers to efficiency.
The London Borough of Bromley is recommissioning the Bromley 0 -19 Children's Public Health Nursing Service. The aim of the 0-19 Public Health Nursing Service is to deliver the Healthy Child Programme for Children and Young People aged 0-19 and plays a critical role in supporting the health, well-being and development of children, young people and families. The Service includes health visiting and school nursing provision, delivering key public health priorities. It is the Council's intention to award a single contract to one provider. The procurement will be undertaken using the Competitive Procedure of the Provider Selection Regime. The contract will commence on 1st October 2027 for a period of 5 years to 30th September 2032.
Network Rail intends to procure a framework for the provision of Operational Property Inspection (OPI) services across its estate. The services will include the inspection, assessment, reporting and management of operational property assets to support statutory compliance, asset condition monitoring and maintenance planning. The framework will be delivered by suitably qualified suppliers in accordance with the specification, service requirements and performance standards set out in the procurement documents.
